<DOC>
	<DOCNO>NCT01933464</DOCNO>
	<brief_summary>This study design investigate whether topical application cromolyn sodium solution able decrease facial redness see patient papulopustular rosacea . Previous work lab Dr. Di Nardo mouse suggest cromolyn may able effect . The study enroll total 10 patient . 5 randomly assign receive cromolyn sodium solution , 5 randomly assign receive placebo solution . All participant instruct apply assigned solution twice daily face . Patients return clinic 3 , 6 , 8 week distribution solution measure efficacy assign solution .</brief_summary>
	<brief_title>An Analysis Effect Topical Cromolyn Sodium Rosacea-associated Erythema</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Erythema</mesh_term>
	<mesh_term>Cromolyn Sodium</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Subject male nonpregnant female , 18 80 year age . Subjects willing able give inform consent . Subjects willing able comply requirement study . Subject clinical diagnosis least mild erythema . Subject stable dose great 3 month medication treatment concurrent medical condition ( include oral contraceptive pill , vasodilator , adrenergic block agent ) OR investigator determine medication unlikely affect patient 's rosacea and/or treatment study Subject general good health opinion investigator . Subject diagnosis Steroid Rosacea Pyoderma Faciale ( rosacea fulminans ) Subject history Carcinoid , Pheochromocytoma , Serotonin Syndrome systemic flushing cause . Subject use facial topical therapy ( OTC drug product prescription product ) reason within prior 28 day Subject use systemic corticosteroid systemic antibiotic ( especially doxycycline , minocycline , tetracycline , metronidazole ) within prior 28 day . Subject laser lightbased treatment rosacea within prior 3 month . Subject systemic retinoids retinoid derivative past 6 month Subject history renal hepatic insufficiency . Subject know hypersensitivity allergy Cromolyn sodium component vehicle . Subject pregnant lactating planning pregnancy duration study Subject treat another investigational device drug within 28 day prior study enrollment intend participate clinical trial concurrent study Subject clinically significant finding , medical history condition ( rosacea ) , opinion Investigator may compromise study , treatment protocol , safety patient treatment allocation . Subject know hypersensitivity allergy tape adhesive material</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Rosacea</keyword>
	<keyword>Cromolyn sodium</keyword>
</DOC>